These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 8006339)
21. Reduction in size of a thyrotropin- and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). Sy RA; Bernstein R; Chynn KY; Kourides IA J Clin Endocrinol Metab; 1992 Mar; 74(3):690-4. PubMed ID: 1740506 [TBL] [Abstract][Full Text] [Related]
22. Combined beta FSH and beta LH response to TRH in patients with clinically non-functioning pituitary adenomas. Somjen D; Tordjman K; Kohen F; Baz M; Razon N; Ouaknine G; Stern N Clin Endocrinol (Oxf); 1997 May; 46(5):555-62. PubMed ID: 9231051 [TBL] [Abstract][Full Text] [Related]
23. Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas. Lania A; Gangi E; Romoli R; Losa M; Travaglini P; Meringolo D; Ambrosi B; Faglia G; Beck-Peccoz P; Spada A Eur J Clin Invest; 2002 May; 32(5):335-40. PubMed ID: 12027873 [TBL] [Abstract][Full Text] [Related]
24. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma. Shimon I; Rubinek T; Bar-Hava I; Nass D; Hadani M; Amsterdam A; Harel G J Clin Endocrinol Metab; 2001 Aug; 86(8):3635-40. PubMed ID: 11502789 [TBL] [Abstract][Full Text] [Related]
25. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma. Pawlikowski Łódź M; Jaranowska M; Fryczak J; Radek M; Świętosławski J; Kunert-Radek J; Winczyk K Endokrynol Pol; 2018; 69(5):526-529. PubMed ID: 30074232 [TBL] [Abstract][Full Text] [Related]
27. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. Snyder PJ; Muzyka R; Johnson J; Utiger RD J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992 [TBL] [Abstract][Full Text] [Related]
28. Gonadotroph adenoma with secondary hypersecretion of testosterone. Chamoun R; Layfield L; Couldwell WT World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183 [TBL] [Abstract][Full Text] [Related]
29. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Dawood MY; Jarrett JC; Choe JK Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337 [TBL] [Abstract][Full Text] [Related]
30. Gonadotrophin and alpha subunit secretion by human 'functionless' pituitary adenomas in cell culture: long term effects of luteinizing hormone releasing hormone and thyrotrophin releasing hormone. Surmont DW; Winslow CL; Loizou M; White MC; Adams EF; Mashiter K Clin Endocrinol (Oxf); 1983 Sep; 19(3):325-36. PubMed ID: 6194923 [TBL] [Abstract][Full Text] [Related]
31. Hypersecretion of gonadotropins by a pituitary adenoma: pituitary dynamic studies and treatment with bromocriptine in one patient. Comtois R; Bouchard J; Robert F Fertil Steril; 1989 Oct; 52(4):569-73. PubMed ID: 2806596 [TBL] [Abstract][Full Text] [Related]
32. Effects of long-term treatment with the gonadotropin-releasing hormone analog nafarelin in patients with non-functioning pituitary adenomas. Colombo P; Ambrosi B; Saccomanno K; Bassetti M; Cortelazzi D; Faglia G Eur J Endocrinol; 1994 Apr; 130(4):339-45. PubMed ID: 8162161 [TBL] [Abstract][Full Text] [Related]
35. Gonadotroph cell adenomas of the pituitary. Snyder PJ Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559 [TBL] [Abstract][Full Text] [Related]
36. Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine. Vance ML; Ridgway EC; Thorner MO J Clin Endocrinol Metab; 1985 Sep; 61(3):580-4. PubMed ID: 2410444 [TBL] [Abstract][Full Text] [Related]
37. Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma? Gruszka A; Kunert-Radek J; Pawlikowski M Endokrynol Pol; 2005; 56(1):14-8. PubMed ID: 16335668 [TBL] [Abstract][Full Text] [Related]
39. LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas. White MC; Daniels M; Newland P; Thompson CJ; Cook D; Dewar J; Perry R; Jewitt R; Mathias D; Murdoch AP Clin Endocrinol (Oxf); 1990 Jun; 32(6):681-8. PubMed ID: 2116944 [TBL] [Abstract][Full Text] [Related]
40. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist. McGrath GA; Goncalves RJ; Udupa JK; Grossman RI; Pavlou SN; Molitch ME; Rivier J; Vale WW; Snyder PJ J Clin Endocrinol Metab; 1993 May; 76(5):1363-8. PubMed ID: 8496331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]